GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dar Al Dawa Development and Investment (AMM:DADI) » Definitions » Scaled Net Operating Assets

Dar Al Dawa Development and Investment (AMM:DADI) Scaled Net Operating Assets : 0.71 (As of Sep. 2024)


View and export this data going back to 1978. Start your Free Trial

What is Dar Al Dawa Development and Investment Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Dar Al Dawa Development and Investment's operating assets for the quarter that ended in Sep. 2024 was JOD106.27 Mil. Dar Al Dawa Development and Investment's operating liabilities for the quarter that ended in Sep. 2024 was JOD21.49 Mil. Dar Al Dawa Development and Investment's Total Assets for the quarter that ended in Jun. 2024 was JOD118.63 Mil. Therefore, Dar Al Dawa Development and Investment's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.71.


Dar Al Dawa Development and Investment Scaled Net Operating Assets Historical Data

The historical data trend for Dar Al Dawa Development and Investment's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dar Al Dawa Development and Investment Scaled Net Operating Assets Chart

Dar Al Dawa Development and Investment Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.67 0.72 0.70 0.70 0.68

Dar Al Dawa Development and Investment Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 0.65 0.68 0.69 0.72

Competitive Comparison of Dar Al Dawa Development and Investment's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Dar Al Dawa Development and Investment's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dar Al Dawa Development and Investment's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dar Al Dawa Development and Investment's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Dar Al Dawa Development and Investment's Scaled Net Operating Assets falls into.



Dar Al Dawa Development and Investment Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Dar Al Dawa Development and Investment's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(96.605-23.9)/107.172
=0.68

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=109.248 - 12.643
=96.605

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=63 - 0.169 - 38.931
=23.9

Dar Al Dawa Development and Investment's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(106.267-21.489)/118.632
=0.71

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=121.559 - 15.292
=106.267

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=72.82 - 0.131 - 51.2
=21.489

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dar Al Dawa Development and Investment Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Dar Al Dawa Development and Investment's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Dar Al Dawa Development and Investment Business Description

Traded in Other Exchanges
N/A
Address
Naour, P.O. Box 9364, Amman, JOR, 11191
Dar Al Dawa Development and Investment is a pharmaceutical company. The main objectives of the company are to manufacture pharmaceutical, chemical, pharmaceutical, and related products and to import medicines. It offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, dermatology, eye-ear preparations, gastroenterology and metabolism, genitourinary system and sex hormones, musculoskeletal system, nervous system, ophthalmological/otological, and respiratory system, as well as vitamins. The company's geographical segments are Levant and Iraq, Gulf and Yemen, Africa, and Europe and Asia.

Dar Al Dawa Development and Investment Headlines

No Headlines